![]() |
市场调查报告书
商品编码
1328989
全球实验室自动化市场评估:按产品、应用、最终用户、地区、机会和预测(2016-2030)Lab Automation Market Assessment, By Product By Application, By End User, By Region, Opportunities and Forecast, 2016-2030F |
全球实验室自动化市场规模预计将从 2022 年的 57.5 亿美元增至 2030 年的 98.2 亿美元,2023-2030 年预测期间复合年增长率为 6.92%。预计该市场在短期内将出现显着增长,这主要是由于研究设备的技术进步以及製药和研发机构越来越多地采用自动化实验室系统。此外,对紧凑型加工设备的需求不断增长也有助于市场扩张。然而,所需的大量初始投资正在阻碍市场增长。
由于对消除人为错误的专业和先进自动化服务的高需求,市场正在呈现显着增长。市场参与者优先提供各种工具、设备、机械和技术来支持自动化实验室基础设施的开发和製造。为了获得更大的全球市场份额,市场公司正在筹集资金进行额外投资并开发先进技术和方法。
实验室机器人正在成为市场的变革力量,为市场带来了巨大的增长机会。科学研究的日益复杂性和对高通量筛选的需求不断增加,正在加速实验室机器人在製药、生物技术、医疗和研究机构等各个行业的采用。
市场上用于药物发现和药物开发的自动化仪器的使用显着增加。这一趋势反映出人们越来越认识到自动化在提高实验室工作流程的效率、准确性和生产力方面所带来的好处。近年来,药物发现实验室自动化集成显着增加,彻底改变了药物研究的进行方式。随着对新的、更有效的治疗方法的需求不断增加,自动化已成为加速药物开发过程和提高整体效率的重要工具。
市场呈现出充满活力的前景,多个主要参与者推动创新和增长。Thermo Fisher Scientific、Agilent Technologies、Siemens Healthineers 和 PerkinElmer 等领先公司凭藉其广泛的产品组合和强大的市场影响力占据了市场主导地位。这些公司不断投资于研发,以实施先进的自动化技术和解决方案。随着对简化实验室工作流程、提高效率和提高数据准确性的需求持续增长,市场前景仍然乐观。机器人系统、人工智能和基于云的自动化平台等技术进步预计将塑造市场的未来。此外,联盟、合作伙伴关係和战略收购可能会加剧竞争并进一步推动市场增长。
本报告研究和分析了全球实验室自动化市场,提供市场规模和预测、市场动态以及主要参与者的现状和前景。
Global Lab Automation Market size was valued at USD 5.75 billion in 2022 and is expected to reach USD 9.82 billion in 2030 with a CAGR of 6.92% for the forecast period between 2023 and 2030. Lab automation is a cutting-edge and interdisciplinary method employed in labs to enhance productivity, minimize time consumption, and improve efficiency in laboratory procedures. The market for lab automation is expected to experience significant growth in the foreseeable future, primarily driven by advancements in technology about laboratory equipment and the increasing adoption of automated laboratory systems in pharmaceutical and research and development (R&D) institutes. Furthermore, the growing demand for compact processing equipment is also a contributing factor to the expansion of the market. However, the substantial initial investment requirement impeded the market's growth.
The lab automation market is witnessing a surge in demand globally, driven by the rapid advancement of technology. Lab automation equipment and tools are extensively utilized in the healthcare sector. With healthcare expenditures rising due to various factors, prominent pharmaceutical and healthcare companies are being propelled to automate their laboratories. This enables them to provide advanced healthcare services conveniently and efficiently, saving time and bringing healthcare services closer to people's doorsteps.
The surging demand for healthcare services has fueled intense competition among leading healthcare and pharmaceutical companies globally to undergo lab automation. This competition has increased the utilization of equipment, analyzers, and software in laboratory settings. Market players are primarily focused on offering a wide range of tools, equipment, machines, and techniques to facilitate the development and manufacturing of automated laboratory infrastructure. To achieve this, market players are making substantial investments and securing funding to develop advanced technologies and methodologies.
The lab automation market is witnessing significant growth due to the high demand for specialized and advanced automated services that eliminate human errors. Both market players and companies prioritize providing diverse tools, equipment, machines, and techniques to support the development and manufacturing of automated laboratory infrastructure. This market expansion is driven by the increasing demand for specialized advanced automated services that can effectively eliminate human error. To capture a larger global market share, market players are making additional investments and securing funding to develop advanced technologies and methodologies. Their primary focus is to reduce manual efforts and hands-on time in traditionally labor-intensive processes.
In June 2022, BD announced the successful completion of the acquisition of Straub Medical AG, a privately owned company. This acquisition has enabled BD to gain valuable expertise and experience of Straub Medical AG while expanding its product portfolio.
In January 2022, Qiagen made two partnership announcements. The first collaboration was with Atila BioSystems, aimed at offering non-invasive prenatal testing solutions to Qiagen's dPCR franchise. The second announcement involved a co-exclusive licensing and co-marketing agreement with Actome GmbH, a life sciences start-up from Germany. This agreement expanded Qiacuity's scope beyond genomics and proteomics.
Laboratory robotics has emerged as a transformative force in the lab automation market, presenting an excellent opportunity for substantial market growth. Integrating robotics in laboratory processes has revolutionized scientific experiments and tasks, offering numerous advantages over traditional manual methods. By automating repetitive and time-consuming tasks, laboratory robotics boosts efficiency and reduces the risk of human error, enhancing overall data accuracy and reliability. The increasing complexity of scientific research and the growing demand for high-throughput screening have accelerated the adoption of laboratory robotics in various industries, including pharmaceuticals, biotechnology, healthcare, and research institutions.
With exceptional precision and speed, these robotics systems can handle various tasks, such as sample handling, liquid handling, plate manipulation, and data analysis. Additionally, laboratory robotics facilitate improved resource management, as they can operate around the clock, optimizing the utilization of expensive lab equipment and reagents. This, in turn, leads to cost savings and higher productivity, making them an attractive investment for companies and institutions seeking to streamline their laboratory workflows.
Opentrons, a leader in lab automation, launched Opentrons Flex robot in May 2023. Opentrons Flex robot is a new generation, affordable and easy-to-program liquid-handling lab robot designed to level the playing field for labs of all sizes and bring advanced lab automation to more researchers than ever before.
The global lab automated market is witnessing remarkable technological advancements, revolutionizing laboratory processes and research methodologies. One key area of progress is the integration of robotics and automation systems, which has significantly improved the efficiency and accuracy of laboratory tasks. Robotic systems can perform repetitive and complex operations with precision, reducing human errors and increasing productivity. Moreover, developing advanced sensors, software, and connectivity solutions has facilitated real-time monitoring, remote access, and seamless data exchange, fostering collaboration among researchers worldwide.
In November 2022, F. Hoffmann -La Roche Ltd. entered into a collaboration with PathAI to improve patient care through utilization of artificial intelligence-based digital pathology applications. As per the agreement for development and distribution, the companies will collaborate on creating an integrated image analysis process specifically designed for pathologists. This process will enable pathologists to use PathAI image analysis algorithms directly within Roche's uPath enterprise software, specifically its cloud-based NAVIFY Digital Pathology version.
The global lab automation market has witnessed a substantial rise in using automated instruments for drug discovery and development. This trend reflects the growing recognition of the advantages offered by automation in enhancing efficiency, accuracy, and productivity in laboratory workflows. In recent years, drug discovery has witnessed a substantial increase in the integration of lab automation, revolutionizing the way pharmaceutical research is conducted. With the ever-growing demand for novel and more effective therapeutics, automation has emerged as a crucial tool to accelerate the drug development process and improve overall efficiency. Automation streamlines various aspects of drug discovery, including high-throughput screening of potential drug compounds, compound synthesis and optimization, and data analysis.
Insilico Medicine, a clinical-stag e company focusses on utilizing artificial intelligence (AI) throughout the drug discovery process, revealed the successful conclusion of its Series D funding round. The company raised USD 60 million from a syndicate of global investors. The capital raised in the round further bolstered Insilico's financial position and fuelled the growth of its advancing pipeline. This included their lead program, which was undergoing a Phase I study at the time, as well as the continued development of their Pharma AI platform.
COVID-19 had a significant impact on the Global lab automation market. The virus outbreak increased the demand for diagnostic testing and research on potential treatments and vaccines. As a result, laboratories worldwide faced a surge in workload and the need for faster and more efficient processes. Lab automation technologies were crucial in meeting these demands by enabling high-throughput testing, sample processing, and data analysis. Automation systems streamlined workflows, reduced manual labour, and minimized the risk of human error, ensuring accurate and timely results. Additionally, the pandemic highlighted the importance of remote monitoring and operation of lab equipment, leading to adoption of cloud-based automation solutions.
In January 2022, the Hubrecht Institute and Genmab developed the 'STRIP-1' test robot, which can analyze 20,000 samples for SARS-CoV-2 testing within a span of 24 hours. This makes the STRIP-1 significantly faster than any other existing system. STRIP-1 can operate effectively with minimal volumes, utilizing smaller quantities of the currently scarce materials worldwide. Additionally, the expenses associated with each test conducted using STRIP-1 will be significantly lower compared to the prevailing testing costs.
The global lab automation market presents a dynamic landscape with several key players driving innovation and growth. Major companies such as Thermo Fisher Scientific, Agilent Technologies, Siemens Healthineers, and PerkinElmer dominate the market due to their extensive product portfolios and strong market presence. These players continuously invest in research and development to introduce advanced automation technologies and solutions. The global lab automation market outlook remains promising as the demand for streamlined laboratory workflows, enhanced efficiency, and improved data accuracy continues to rise. Technological advancements, such as robotic systems, artificial intelligence, and cloud-based automation platforms, are expected to shape the market's future. Moreover, collaborations, partnerships, and strategic acquisitions will likely intensify competition and further fuel market growth.
PerkinElmer, Inc. introduced readily available Adeno-associated Virus Vectors (AAV) Detection Kits in 2022, assisting scientists in gene therapy research for diverse severe illnesses. These high-throughput viral assays are purposefully developed to expedite and simplify the characterization of viral vector particles, aiding researchers in making informed decisions for secure and effective gene transfer.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work